MILNACIPRAN HYDROCHLORIDE | N022256 | ABBVIE INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
FOREST LABORATORIES HOLDINGS, LTD. et al v. STRIDES PHARMA GLOBAL PTE LIMITED et al 3 patentsANDA 207399milnacipran hydrochloride | D.N.J. | 2017-10-06 | Terminated 2018-04-27 | — |
Forest Laboratories Holdings, Ltd. et al v. Strides Pharma Global PTE Limited et al 3 patentsANDA 207399milnacipran hydrochloride | D. Del. | 2017-10-05 | Terminated 2018-04-26 | — |
Forest Laboratories Inc. et al v. Lupin Limited et al 3 patentsANDA 205286milnacipran hydrochloride | D. Del. | 2013-09-23 | Terminated 2016-05-13 | — |
Forest Laboratories Holdings Ltd. et al v. Apotex Corp. et al 3 patentsANDA 205362milnacipran hydrochloride | D. Del. | 2013-09-23 | Terminated 2016-07-11 | — |
Forest Laboratories Inc. et al v. Par Pharmaceutical Inc. 3 patentsANDA 205062milnacipran hydrochloride | D. Del. | 2013-09-23 | Terminated 2015-05-04 | — |
Forest Laboratories Inc. et al v. Mylan Inc. et al 3 patentsANDA 205367milnacipran hydrochloride | D. Del. | 2013-09-23 | Terminated 2016-07-11 | — |
Forest Laboratories Inc. et al v. Hetero USA Inc. et al 3 patentsANDA 205147milnacipran hydrochloride | D. Del. | 2013-09-23 | Terminated 2015-12-14 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7994220 | Sep 19, 2029 | — | — | — | — |